Indeed, in a recent meta-analysis, approximately 95% of all CeD patients were shown to possess at least one copy of the HLA-DQB1*02 allele that encodes the β chain of the DQ2 heterodimer [8]. The gene discussed is TOR1A; the disease is cranioectodermal dysplasia.